Multimodal deep learning algorithm as a tool for Dementia clinical trial patient disease screening
Abstract Number:
2661
Submission Type:
Contributed Abstract
Contributed Abstract Type:
Paper
Participants:
William Jin (1), Ying Liu (2), Polina Vyniavska (2)
Institutions:
(1) West Windsor - Plainboro High School North, N/A, (2) Princeton Pharmatech LLC, N/A
Co-Author(s):
First Author:
Presenting Author:
Abstract Text:
Dementia is a complex disease due to various etiologies. New multimodal deep learning algorithms were developed to improve the diagnosis of dementia into different categories of normal cognition (NC), mild cognitive impairment (MCI), AD, and non-AD dementias (nADD).
One of the core difficulties in implementing Dementia clinical trials, especially the AD trials lies in the diagnostic ambiguity of Alzheimer's, where symptomatic overlap with other cognitive disorders often leads to misdiagnosis. Dementia clinical trials usually have high screen failure rates and burden for the sponsor for the manual inclusion screening verification.
In our work, we explore the use of this multimodal deep learning algorithm as a tool for the clinical trial patient disease screening verification to reduce the cost of the clinical study while improving the quality. We will present the accuracy assessment of the deep learning algorithm compared to the neurologist assessment based on the sensitivity, specificity, PPV and NPV in the real-world clinical trial setting. We will explore the optimal set of input variables used for the algorithm to balance the accuracy and cost and time of the medical exams.
Keywords:
multimodal deep learning algorithm |Dementia clinical trial|disease screening|sensitivity, specificity, PPV and NPV|real world|
Sponsors:
Biopharmaceutical Section
Tracks:
Trial Monitoring
Can this be considered for alternate subtype?
Yes
Are you interested in volunteering to serve as a session chair?
No
I have read and understand that JSM participants must abide by the Participant Guidelines.
Yes
I understand that JSM participants must register and pay the appropriate registration fee by June 1, 2024. The registration fee is non-refundable.
I understand
You have unsaved changes.